Colorectal cancer - capecitabine and tegafur uracil
Capecitabine and tegafur uracil for metastatic colorectal cancer
Summary
NICE has recommended that capecitabine or tegafur with uracil (and folinic acid), to be taken by mouth, should be among the first options considered for a person with metastatic colorectal cancer. The choice about which medicine to take should be made jointly by the patient and his or her doctor, an ...
In April 2006, following consultation, the Institute decided to make this guidance 'static.' This means that the guidance remains in force and has no scheduled review date. See the review decision, under 'Background information', for further details.
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA61
Issued: May 2003
How this guidance was produced